Linezolid for drug-susceptible tuberculosis.

Ahmed, Saiam; Moore, David Aj; Nimmo, Camus; Nunn, Andrew J; Yates, Tom A

Ahmed, Saiam; Moore, David Aj; Nimmo, Camus; Nunn, Andrew J; Yates, Tom A.

Afiliação

Ahmed S; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London (UCL), London WC1V 6LJ, UK. Electronic address: saiam.ahmed@ucl.ac.uk.
Moore DA; Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
Nimmo C; Division of Infection and Immunity, UCL, London, UK.
Nunn AJ; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London (UCL), London WC1V 6LJ, UK.
Yates TA; Section of Infectious Diseases and Immunity, Imperial College London, London, UK.

Lancet Infect Dis ; 19(4): 357, 2019 04.

Article em En | MEDLINE | ID: mdl-30938294

Assuntos

Tuberculose Pulmonar; Tuberculose; Etambutol; Humanos; Linezolida; Estudos Prospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Tuberculose Pulmonar Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google